GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (STU:CJH) » Definitions » Common Stock

CanSino Biologics (STU:CJH) Common Stock : €876.75 Mil (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CanSino Biologics Common Stock?

CanSino Biologics's quarterly common stock declined from Dec. 2023 (€31.78 Mil) to Mar. 2024 (€31.61 Mil) but then increased from Mar. 2024 (€31.61 Mil) to Jun. 2024 (€876.75 Mil).

CanSino Biologics's annual common stock declined from Dec. 2021 (€34.38 Mil) to Dec. 2022 (€33.51 Mil) and declined from Dec. 2022 (€33.51 Mil) to Dec. 2023 (€31.78 Mil).


CanSino Biologics Common Stock Historical Data

The historical data trend for CanSino Biologics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics Common Stock Chart

CanSino Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial 28.57 31.11 34.38 33.51 31.78

CanSino Biologics Quarterly Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.89 31.77 31.78 31.61 876.75

CanSino Biologics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


CanSino Biologics Business Description

Address
185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.

CanSino Biologics Headlines

No Headlines